Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_assertion type Assertion NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_head.
- NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_assertion description "[We have previously demonstrated an association of the human leukocyte antigen (HLA), HLA-A2 allele with ovarian and prostate cancer mortality as well as a segregation of the ancestral HLA haplotype (AHH) 62.1 [(A2) B15 Cw3 DRB1*04] in patients with stage III-IV serous ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_provenance.
- NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_assertion evidence source_evidence_literature NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_provenance.
- NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_assertion SIO_000772 19214504 NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_provenance.
- NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_assertion wasDerivedFrom befree-2016 NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_provenance.
- NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_assertion wasGeneratedBy ECO_0000203 NP720335.RA5NVKi5oe36sMP1GYTPnkHUeL4Z2ntRdfN-VEjbDX3NI130_provenance.